Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Monthly Cabotegravir-Rilpivirine Injections Superior to Standard Oral ART for HIV With ...

South Africa Time — Monday, March 09, 2026

Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral ART in persons with HIV and medication adherence ...

View article...

Racial Xperience

Top stories of the last 30 days

Kenya becomes first in East Africa to launch six-month HIV prevention injection

South Africa Time — Thursday, February 26, 2026

Years later, Mutua, now 27, has become the first Kenyan to receive lenacapavir, a new injectable option that protects against HIV for six months with ... View article...

Seven People Have Been Cured Of HIV After Receiving A Specific Cancer Treatment

South Africa Time — Monday, March 02, 2026

For many years, HIV was among the most feared diseases in the world. Getting it was essentially a death sentence, and that death was especially ... View article...

Western leads new international, public-private initiative for equitable access to HIV cure

South Africa Time — Wednesday, March 04, 2026

After decades of progress in HIV treatment and vaccine development, the internationally renowned virologist has seen both the extraordinary power of ... View article...

Analysis of 9vHPV Vaccination Benefits in Men With HIV

South Africa Time — Thursday, February 26, 2026

Mixed vaccine impact means MSM with HIV still need ongoing anal cancer screening. View article...

Retention in care and viral suppression in people living with HIV and chronic hepatitis B in ...

South Africa Time — Tuesday, March 03, 2026

Early antiretroviral treatment (ART) has reduced mortality among people living with HIV (PLHIV), but outcomes for HIV -HBV coinfected people in ... View article...

One2PrEP Takes HIV Prevention to Center Stage, Using Culture and Conversation to Break Stigma

South Africa Time — Wednesday, March 04, 2026

Gilead has now developed an awareness campaign, One2PrEP, aimed at having public conversations about HIV prevention and that they belong in the ... View article...

'DNA origami' could be key for making an effective HIV vaccine, early study hints

South Africa Time — Thursday, February 12, 2026

A vaccine designed using "DNA origami" activated more of the key immune cells needed to fight HIV than did traditional vaccines built upon protein ... View article...

HIV Gene Expression Detection Tool Opens Viral Treatment Directions

South Africa Time — Wednesday, March 04, 2026

For people living with human immunodeficiency virus (HIV), antiretroviral therapy prevents HIV-infected immune cells from replicating the virus to ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

South Africa pushes for local production of HIV prevention drug lenacapavir

South Africa Time — Thursday, March 05, 2026

South Africa is seeking to produce a key HIV prevention drug locally as part of a broader effort to improve access to treatment and strengthen the ... View article...

Gilead, South Africa negotiate license to produce HIV drug locally

South Africa Time — Thursday, March 05, 2026

The South African government is negotiating a deal with Gilead Sciences to allow domestic production of a groundbreaking HIV prevention medicine ... View article...

CXCR4-tropic HIV-1 infection in an immunocompetent monkey model

South Africa Time — Monday, March 09, 2026

Current animal models of HIV -1 infection are either immunocompromised or rely on proxy viruses instead of HIV -1. Here, we establish an ... View article...

Comprehensive National PrEP Bills to Prevent HIV Introduced

South Africa Time — Thursday, March 05, 2026

The PrEP Access and Coverage Act of 2026 guarantees insurance coverage and creates a national grant program for PrEP to prevent HIV . View article...

Inside the world's fastest-growing HIV epidemic

South Africa Time — Monday, March 09, 2026

More than 1200 people in Fiji were diagnosed with HIV the first six months of 2025, making the island nation's HIV epidemic the fastest growing in ... View article...

Evidence reveals cross-country price variation for the procurement of HIV treatment

South Africa Time — Thursday, March 05, 2026

... HIV medicines. The procurement of ARVs is a recurring, lifelong cost for every country that that represent the single largest and most non ... View article...

South Africa's Gambit to Revolutionise HIV Treatment

South Africa Time — Monday, March 09, 2026

South Africa is pushing for local manufacturing of lenacapavir, a twice-yearly HIV injection, aiming to boost regional supply, reduce costs, ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews